V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260009032 | 260005929 | 1.77 | 76 | Curative (C) | 2017-03-02 | 2017-03-15 | Rituximab | 02 | N | 260029084 | RITUXIMAB |
| 260009033 | 260005929 | 1.67 | 134.9 | Palliative (P) | 2016-04-20 | 2016-04-26 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE | N | N | 260029084 | CARBOPLATIN + ETOPOSIDE |
| 260009034 | 260005930 | 0 | 74.6 | null | 2014-03-16 | 2014-03-17 | AML16 DA 3+10 | 02 | null | 260029091 | RITUXIMAB |
| 260009035 | 260005930 | 1.87 | 78.4 | Palliative (P) | 2016-05-06 | 2016-05-10 | TIP | 02 | N | 260029091 | CHOP |
| 260009036 | 260005931 | 1.73 | null | Palliative (P) | 2017-08-06 | 2017-08-21 | Enzalutamide | 2 | N | 260029093 | RITUXIMAB |
| 260009037 | 260005931 | 1.83 | 74.6 | Curative (C) | 2016-04-12 | 2016-04-18 | Cisplatin + Etoposide (5 day) | 2 | N | 260029093 | RITUXIMAB |
| 260009038 | 260005931 | null | 82.4 | Not known (9) | null | 2015-06-06 | CYCLO + RITUXIMAB + VINCRISTINE | null | null | 260029093 | ESHAP |
| 260009039 | 260005932 | 1.87 | 57 | Palliative (P) | 2017-11-05 | 2017-11-08 | Rituximab | N | N | 260029099 | ESHAP |
| 260009040 | 260005932 | null | 76.1 | Curative (C) | 2016-02-14 | 2016-02-14 | Bendamustine +/- Prednisolone | N | N | 260029099 | RITUXIMAB |
| 260009041 | 260005933 | 1.65 | 76.8 | Curative (C) | 2015-05-13 | 2015-05-18 | FLUOROURACIL + MITOMYCIN + RT | 02 | Y | 260029102 | ABVD |
| 260009042 | 260012125 | 1.73 | 105 | null | null | 2013-09-01 | CISPLATIN + ETOPOSIDE | null | null | 260029107 | BENDAMUSTINE |
| 260009043 | 260012125 | 1.84 | 63 | Palliative (P) | 2015-06-16 | 2015-06-28 | CHLORAMBUCIL + RITUXIMAB | N | N | 260029107 | FLUOROURACIL + MITOMYCIN + RT |
| 260009044 | 260012125 | null | 106.4 | Palliative (P) | 2013-04-21 | 2013-05-05 | Bendamustine +/- Prednisolone | N | N | 260029107 | CHOP |
| 260009045 | 260005934 | 1.78 | null | Curative (C) | 2016-05-02 | 2016-05-14 | R ABVD | 02 | N | 260029111 | NOT MATCHED |
| 260009046 | 260012126 | 1.81 | 68.8 | Disease modification (D) | 2016-09-16 | 2016-10-17 | null | N | N | 260029112 | CYCLO + RITUXIMAB + VINCRISTINE |
| 260009047 | 260005935 | 1.63 | 74.25 | null | 2016-02-08 | 2016-02-17 | Rituximab (Maintenance) | 02 | N | 260029113 | CHLORAMBUCIL + RITUXIMAB |
| 260009048 | 260005935 | 1.8 | 75 | Palliative (P) | null | 2015-10-06 | Rituximab (SUBCUTANEOUS Maintenance) | 02 | N | 260029113 | RITUXIMAB |
| 260009049 | 260005936 | 1.59 | 62 | null | null | 2013-11-05 | Rituximab | null | null | 260029117 | NOT MATCHED |
| 260009050 | 260005936 | 1.57 | null | Palliative (P) | 2014-05-15 | 2014-05-16 | PACIFICO TRIAL | N | N | 260029117 | CARBOPLATIN + PACLITAXEL |
| 260009051 | 260005937 | 1.68 | null | Palliative (P) | 2014-11-10 | 2014-11-16 | Trial Unspecified | N | N | 260029122 | BRENTUXIMAB |
| 260009052 | 260012129 | 1.8 | 10.8 | Neo-adjuvant (N) | 2014-11-29 | 2014-12-20 | ABVD | N | N | 260029128 | CHOP R + METHOTREXATE |
| 260009053 | 260012129 | 1.62 | 52 | Neo-adjuvant (N) | 2014-09-22 | 2014-09-24 | Rituximab | N | N | 260029128 | RITUXIMAB |
| 260009054 | 260005938 | 1.75 | 101.6 | Curative (C) | 2016-10-14 | 2016-10-27 | CISPLATIN + GEMCITABINE | 02 | N | 260029130 | IVE-R |
| 260009055 | 260005938 | 1.66 | null | Curative (C) | null | 2016-01-17 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | 260029130 | CHLORAMBUCIL |
| 260009056 | 260005939 | null | 57.2 | null | null | 2017-02-15 | CYCLO + RITUXIMAB + VINCRISTINE | N | N | 260029135 | RITUXIMAB |
| 260009057 | 260005939 | 1.86 | 86.06 | Curative (C) | null | 2018-07-05 | Vincristine (weekly) | N | N | 260029135 | RITUXIMAB |
| 260009058 | 260005940 | 1.83 | 72 | Adjuvant (A) | 2015-02-19 | 2015-02-26 | CYCLO + RITUXIMAB + VINCRISTINE | N | N | 260029140 | RITUXIMAB |
| 260009059 | 260012132 | null | 109 | Disease modification (D) | 2015-04-03 | 2015-04-16 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 2 | N | 260029143 | RITUXIMAB |
| 260009060 | 260005941 | null | 57.4 | Palliative (P) | null | 2018-07-20 | Bendamustine +/- Prednisolone | N | null | 260029144 | ICE-R |
| 260009061 | 260012133 | 1.71 | 67.9 | Curative (C) | 2015-05-09 | 2015-05-24 | DA-EPOCH-R | N | N | 260029145 | BENDAMUSTINE |
| 260009062 | 260005942 | 1.85 | 66.4 | null | null | 2017-09-23 | Rituximab (Maintenance) | N | N | 260029146 | NOT MATCHED |
| 260009063 | 260012134 | null | 76.4 | Curative (C) | null | 2016-04-26 | Bendamustine +/- Prednisolone | null | null | 260029149 | RITUXIMAB |
| 260009064 | 260005943 | 1.85 | 82 | Curative (C) | 2016-10-23 | 2016-10-31 | Rituximab | N | N | 260029151 | RITUXIMAB |
| 260009065 | 260012135 | 1.67 | 85.6 | Adjuvant (A) | 2014-06-22 | 2014-06-22 | FCR Oral Lite | 02 | N | 260029152 | RITUXIMAB |
| 260009066 | 260005944 | 1.7 | null | Curative (C) | 2015-03-08 | 2015-03-15 | R-CHOEP | N | N | 260029154 | RITUXIMAB |
| 260009067 | 260005944 | 1.63 | 0 | null | 2017-09-02 | 2017-09-09 | Bendamustine +/- Prednisolone | null | null | 260029154 | RITUXIMAB |
| 260009068 | 260005945 | 1.74 | null | Curative (C) | 2019-03-07 | 2019-03-20 | Rituximab | N | N | 260029160 | CHLORAMBUCIL + RITUXIMAB |
| 260009069 | 260005946 | 1.72 | 81.6 | Curative (C) | null | 2014-05-04 | Rituximab | N | N | 260029161 | EP |
| 260009070 | 260005946 | null | 69.6 | Curative (C) | 2018-07-20 | 2018-08-03 | RCEOP | N | N | 260029161 | CHLORAMBUCIL + RITUXIMAB |
| 260009071 | 260005946 | null | 90.3 | Curative (C) | 2016-07-31 | 2016-08-07 | Bendamustine +/- Prednisolone | N | N | 260029161 | CHLVPP |
| 260009072 | 260005947 | 1.6 | 69.5 | Curative (C) | 2018-05-11 | 2018-05-11 | CHOP - 21 days | null | Y | 260029166 | RITUXIMAB |
| 260009073 | 260005948 | 1.57 | null | Disease modification (D) | 2013-12-16 | 2013-12-16 | Rituximab | 02 | N | 260029167 | CARBOPLATIN + PACLITAXEL |
| 260009074 | 260005949 | null | 72 | Curative (C) | null | 2017-04-08 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE | null | null | 260029168 | RITUXIMAB |
| 260009075 | 260005949 | 1.76 | 55.7 | null | 2016-04-24 | 2016-05-09 | CARBOPLATIN + ETOPOSIDE | 02 | Y | 260029168 | TIP |
| 260009076 | 260005950 | null | 48.9 | Curative (C) | null | 2014-03-30 | R Chlorambucil | null | null | 260029170 | CHOP |
| 260009077 | 260012139 | null | 114.3 | Palliative (P) | null | 2017-11-15 | Rituximab (Maintenance) | null | null | 260029176 | CARBOPLATIN + ETOPOSIDE |
| 260009078 | 260012139 | 1.75 | 106.5 | Disease modification (D) | 2018-01-24 | 2018-01-25 | Cyclophosphamide High Dose | N | N | 260029176 | BENDAMUSTINE |
| 260009079 | 260005951 | 1.71 | 86.7 | Curative (C) | 2018-06-23 | 2018-06-27 | Bortezomib (weekly) | 02 | N | 260029180 | CHLORAMBUCIL + RITUXIMAB |
| 260009080 | 260005951 | 1.73 | 67.7 | null | 2016-12-14 | 2016-12-14 | Rituximab (Maintenance) | N | null | 260029180 | RITUXIMAB |
| 260009081 | 260005952 | 1.68 | 70 | Disease modification (D) | 2017-06-28 | 2017-07-05 | ABVD | 02 | N | 260029182 | RITUXIMAB |